Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:6/1/2018
Start Date:May 2011
End Date:December 2019
Contact:Philip F Halloran, MD PhD
Email:phallora@ualberta.ca
Phone:1 780 492-6160

Use our guide to learn which trials are right for you!

Multi-centric Observational Study to Analyse the Diagnostic Molecular Features in the Clinical Setting of Kidney Allograft Biopsies

The current standard for biopsy-based diagnoses of dysfunction of kidney transplants is the
Banff Classification which represents arbitrary international consensus. Recent data-driven
approaches using molecular and conventional technologies indicate that mere consensus
produces frequently incorrect diagnoses with potential harm to patients due to inappropriate
treatment. To address this unmet need and improve diagnostics in the area of organ
transplantation, the Alberta Transplant Applied Genomics Centre (ATAGC) has developed a new
diagnostic system that combines the molecular and histopathological features of transplant
biopsies, plus clinical and laboratory parameters, to create the first Integrated Diagnostic
System. The present study will validate and refine this system in 500 prospectively
unselected biopsies for clinical indications from American, Canadian and European centres in
addition to 300 biopsies already collected. Due to a considerable interest and support from
participating Centers, the study is further extended to 1200 prospective biopsies. Thus this
is the extension of the INTERCOM study (INTERCOMEX). In addition to demonstrating the
feasibility and value of this System in routine patient care and clinical trials, the study
will develop and optimize a transparent and user-friendly reporting format to communicate
this information to clinicians and obtain detailed feedback on how this system can best
improve patient care.

The study is now enrolling (N=1100) and the results were analyzed for the first 300 collected
biopsies. Follow-up data is, and will be collected.

Inclusion Criteria:

- All kidney transplant recipients ≥18yrs of age undergoing a kidney biopsy for clinical
indications, as determined by their physician or surgeon, will be eligible to enrol in
the study.

Exclusion Criteria:

- Patients will be excluded from the study if they decline participation or are unable
to give informed consent.
We found this trial at
11
sites
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
Principal Investigator: Milagros D Samaniego-Picota, MD
Phone: 734-771-9819
University of Michigan Health System The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
750 Highland Avenue
Madison, Wisconsin 53792
Principal Investigator: Arjang Djamali, MD, MS
Phone: 608-263-0383
?
mi
from
Madison, WI
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
655 West Baltimore Street
Baltimore, Maryland 21201
(410) 706-7410
Principal Investigator: Jonathan Bromoberg, MD PhD
University of Maryland School of Medicine Established in 1807, The School of Medicine is the...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Birmingham, Alabama 35294
Principal Investigator: Roslyn Mannon, MD
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Harrisburg, Pennsylvania
Principal Investigator: Harold Yang, MD
?
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Richmond, Virginia 23235
Principal Investigator: Gaurav Gupta, MD
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Antonio, Texas
Principal Investigator: . Adam Bingaman, MD
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Vienna,
Principal Investigator: Georg Boehmig, MD PhD
?
mi
from
Vienna,
Click here to add this to my saved trials